Differential diagnosis of hyperferritinemia
How to approach the differential diagnosis of hyperferritinemia?
How to approach the differential diagnosis of hyperferritinemia?
What diet, medication, and physical activity should be recommended to a patient with hemochromatosis?
Is a very high platelet number (>1-1.5 million/microL) an indication for cytoreductive treatment in patients with essential thrombocythemia (ET)?
What are the indications to perform screening coagulation tests?
What are the target complete blood count (CBC) values in patients receiving cytoreductive treatment for essential thrombocythemia (ET)?
What tests do you perform in a patient with a suspected bleeding disorder who has normal coagulation screening test results (platelet count, prothrombin time, partial thromboplastin time, thrombin time, fibrinogen)?
Patients with monoclonal gammopathy of unknown significance (MGUS) are at low risk for progression to plasma cell myeloma (multiple myeloma). Who should take care of these patients: hematologists and oncologists? Or general practitioners?
Should von Willebrand factor testing be repeated before excluding the diagnosis of von Willebrand disease?
In patients with a viral respiratory tract infection the complete blood count (CBC) may reveal transient abnormalities. One such finding is a reduced neutrophil count, which usually does not fulfil the criteria of neutropenia but raises concerns of worsening or a more serious underlying condition. How should we interpret such results and approach such patients? What should we pay attention to?